ArticleThe Journal of infectious diseases2015

Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.

Emily A Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.